![]() |
市場調査レポート
商品コード
1380422
ヘルスケアにおけるコンピュータビジョンの世界市場:2023-2030年Global Computer Vision in Healthcare Market 2023-2030 |
||||||
カスタマイズ可能
|
ヘルスケアにおけるコンピュータビジョンの世界市場:2023-2030年 |
出版日: 2023年09月27日
発行: Orion Market Research
ページ情報: 英文 180 Pages
納期: 2~3営業日
|
ヘルスケアにおけるコンピュータビジョンの世界市場は、予測期間(2023-2030年)にCAGR 43.2%で成長すると予測されています。コンピュータビジョンは、画像診断、病理学、外科手術、患者モニタリング、創薬、遠隔医療など、ヘルスケアにおける幅広い用途があります。コンピュータビジョンの使用は、エラーの可能性を減らし、病気の診断、外科的介入、遠隔患者評価のスピードと精度を向上させ、最終的に医療成果の向上につながります。これとは別に、費用対効果の高いソリューションに対する需要の高まりや医療ミスの減少も、コンピュータビジョンの採用を後押ししています。これらの複合的な要素が、患者ケアの強化とヘルスケアシステムの効率化に重要な役割を果たしています。
タイプ別では、医療機器が大きなシェアを占めると予想されます。コンピュータビジョンベースの医療機器はヘルスケアに幅広く応用され、患者のケアや診断精度を大幅に向上させる。画像診断、病理学的分析、外科手術の精密さなどに使用され、より正確な医療評価と治療を保証します。これとは別に、これらの機器は遠隔患者モニタリング、遠隔医療相談、歯科画像診断、眼科評価に使用されており、これらすべてがヘルスケアサービスの効率と効果に貢献しています。
ヘルスケアにおけるコンピュータビジョンの世界市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、その他アジア太平洋地域(中東とアフリカ、ラテンアメリカ)を含む地域別にさらに細分化されます。このうち北米は、ヘルスケアへのアクセスの良さ、エンドユーザー産業における市場リーダーの存在感の大きさなどの要因から、市場でかなりのシェアを占めています。さらに、AI/MLなどの先端技術への投資の増加や技術の進歩もあります。例えば、2023年2月、Modular DevicesとO2 Investment Partnersのポートフォリオ企業は、Interim Diagnostic Imagingに非公開の金額を投資しました。この提携により、同社は研究開発と製品ポートフォリオの拡充に注力します。
国際通貨基金によると、アジア太平洋地域は世界人口の60%を占めています。世界人口の大半を占め、著しく成長していることから、同地域の政府は、より良い政策の導入、投資、ヘルスケア効率を向上させるためのAI/MLなどの先進技術の導入により、ヘルスケアシステムの改善に注力しています。さらに、主要な地域経済は、医療機器や病院産業などのエンドユーザー産業を促進するための政策も導入しています。例えば、2022年7月、インド政府は、インドで販売される医療品目が信頼性が高く、効率的で、要求される基準に適合していることを保証し、徹底した法的保護を提供するために、新しい医薬品・医療機器・化粧品法案2022の草案を提出しました。こうした取り組みは、SigTupleやQure.aiのような地域企業が国際市場で競争力を維持するのにも役立っています。
Title: Global Computer Vision in Healthcare Market Size, Share & Trends Analysis Report by Type (Hardware, Software, and Services), by Application (Medical Imaging & Diagnostics, Surgeries, Patient Monitoring, and Others), and by End User (Healthcare Providers, Diagnostic Centers, Academic Research Institutes, and Others)Forecast Period (2023-2030).
The global computer vision in the healthcare market is anticipated to grow at a CAGR of 43.2% during the Forecast Period (2023-2030). Computer vision has a wide range of applications in healthcare such as diagnostic imaging, pathology, surgical procedures, patient monitoring, drug discovery, and telemedicine, among others. Usage of computer vision reduces the chances of errors and improves speed, and accuracy of disease diagnosis, surgical interventions, and remote patient assessments, ultimately leading to enhanced healthcare outcomes. Apart from this, the growing demand for cost-effective solutions, and decreased medical errors, are all driving its adoption. These combined elements play a crucial role in enhancing patient care and streamlining the efficiency of the healthcare system.
The global computer vision in healthcare market is segmented based on the type, application, and end user. Based on type, the market is sub-segmented into software, hardware, and services. Based on application, the market is sub-segmented into medical imaging & and diagnostics, surgeries, patient monitoring, and other applications such as drug discovery, patient education, and rehabilitation. Based on end users, the market is sub-segmented into healthcare providers, diagnostic centers, academic research institutes, and others such as pharmaceutical companies, and medical device companies. Among the end users, significant demand for computer vision-based solutions is growing in the pharmaceutical industry. In pharmaceutical manufacturing, computer vision can be used for multiple applications such as quality inspection of a product, packaging detection, classification of imprinted pharmaceutical labels, and cleaning inspections. Getting stringent FDA regulations to maintain and improve product quality, the continuous growth of the pharmaceutical industry, and growing support from regulators for the inclusion of new technologies such as AI/ML in the manufacturing processes are driving demand for computer vision technology in the pharmaceutical industry. For instance, according to the USFDA quality system regulation for devices, Manufacturers must establish and follow quality systems to help ensure that their products consistently meet applicable requirements and specifications. Considering growing demand and use cases, technology companies are also focusing on products related to the pharmaceutical industry.
Among the types, the medical devices sub-segment is anticipated to hold a prominent share of the market. Computer vision-based medical devices have a wide range of applications across healthcare, significantly enhancing patient care and diagnostic accuracy. They are used in diagnostic imaging, pathology analysis, and surgical precision, ensuring better and more precise medical assessments & and treatments. Apart from this, these devices are used for remote patient monitoring, telemedicine consultations, dental imaging, and ophthalmology assessments, all of which collectively contribute to the efficiency and effectiveness of healthcare services.
The global computer vision in the healthcare market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America holds a considerable share in the market due to factors such as better accessibility of healthcare, and the significant presence of market leaders in end-user industries. Furthermore, the growing investments in advanced technologies such as AI/ML, and technological advancements. For instance, in February 2023 Modular Devices and the portfolio company of O2 Investment Partners invested an undisclosed amount in Interim Diagnostic Imaging. With this partnership, the company will focus on research and development, and product portfolio expansion.
Asia-Pacific region holds 60% of the global population, according to the International Monetary Fund. With a majority share of the global population, which is growing significantly, the regional governments are focusing on improving healthcare systems by introducing better policies, investments, and the inclusion of advanced technologies such as AI/ML to improve healthcare efficiency. Additionally, the major regional economies are also introducing policies to promote end-user industries such as medical devices, and hospitals industry. For instance, In July 2022, the government of India tabled a draft for the new Drugs, Medical Devices and Cosmetics Bill 2022, to assure and offer thorough legal protections to ensure that the medical items sold in India are reliable, efficient, and up to required standards. These initiatives are also helping regional companies such as SigTuple, and Qure.ai to stay competitive in the international market.
The major companies serving the global computer vision in healthcare include: Enlitic, Inc., Caption Health, Inc., Infervision Medical Technology Co., Ltd., and Medtronic, plc among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, and funding to stay competitive in the market. For instance, in January 2022, DarioHealth Corp. acquired Physimax Technologies Ltd. Physimax Technologies is a provider of computer vision technology utilized for Musculoskeletal (MSK) functional screening and predictive risk assessment of injuries. This technology is currently in commercial use by various organizations, including NBA and NFL teams, the US military, and healthcare facilities specializing in orthopedic care.